Evidence map›Paper›PMID 32859580›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer.

Mary Falcone, Chongliang Luo, Yong Chen, David Birtwell, Martin Cheatle, Rui Duan, Peter E Gabriel, Lifang He, Emily M Ko, Heinz-Josef Lenz and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The contribution of nonmedical opioid use to healthcare encounters for opioid overdose and use disorders among long-term users with metastatic cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Mary Falcone *USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.ORCID 0000-0002-8451-2438
Chongliang Luo *Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
Yong ChenDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
David BirtwellUSC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Martin CheatleDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Rui DuanDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
Peter E GabrielDepartment of Radiation Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania.ORCID 0000-0002-3772-9669
Lifang HeDepartment of Computer Science and Engineering, Lehigh University, Bethlehem, Pennsylvania.
Emily M KoDepartment of Obstetrics and Gynecology, University of Pennsylvania Health System, Philadelphia, Pennsylvania.
Heinz-Josef LenzUSC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Nebojsa MirkovicClinical Research Informatics Core, University of Pennsylvania, Philadelphia, Pennsylvania.
Danielle L MoweryDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-3802-4457
E Andrew OchrochDepartment of Anesthesiology and Critical Care, University of Pennsylvania Health System, Philadelphia, Pennsylvania.
E Carter PaulsonDepartment of General Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania.ORCID 0000-0002-5037-6298
Emily SchriverClinical Research Informatics Core, University of Pennsylvania, Philadelphia, Pennsylvania.
Robert A SchnollDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-4089-856X
Justin E Bekelman *Department of Radiation Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania.
Caryn Lerman *USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California. caryn.lerman@med.usc.edu.
University of Pennsylvania · USUniversity of Southern California · USTemple University Health System · USCollege Opportunity Resources for Education · USUniversity of Pennsylvania Health System · USLehigh University · USPhiladelphia VA Medical Center · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MYLES G COCKBURN · 1985 to 2026
$181.4M
Neuroscience-based Interventions for Cancer Risk Behavior ChangeR35CA197461 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LERMAN, CARYN · 2015 to 2021
$6.0M
NCI NIH HHS P30 CA014089NCI NIH HHS R35 CA197461
6 · The paper itself

Abstract

backgroundThe opioid crisis has reached epidemic proportions, yet risk of persistent opioid use following curative intent surgery for cancer and factors influencing this risk are not well understood.

methodsWe used electronic health record data from 3,901 adult patients who received a prescription for an opioid analgesic related to hysterectomy or large bowel surgery from January 1, 2013, through June 30, 2018. Patients with and without a cancer diagnosis were matched on the basis of demographic, clinical, and procedural variables and compared for persistent opioid use.

resultsCancer diagnosis was associated with greater risk for persistent opioid use after hysterectomy [18.9% vs. 9.6%; adjusted OR (aOR), 2.26; 95% confidence interval (CI), 1.38-3.69;

conclusionsPatients with cancer may have an increased risk of persistent opioid use following hysterectomy. IMPACT: Risks and benefits of opioid analgesia for surgical pain among patients with cancer undergoing hysterectomy should be carefully considered.

Indexed as

Analgesics, OpioidFemaleHumansMaleMiddle AgedNeoplasmsSurgical Procedures, OperativeAnalgesics, Opioid

Identifiers

PMID32859580
PMCPMC8074574
OpenAlexW3082199698

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.